Ireland· IE-PA-PA1113/022/001
Medijel oromucosal gel Lidocaine hydrochloride 0.66% w/w Aminoacridine hydrochloride 0.05% w/w
A lidocain, kombinationen product containing aminacrine hydrochloride + lignocaine hydrochloride, registered in Ireland by Phoenix Labs. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lidocain, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC N01BB52 (lidocain, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Lidocain, kombinationen · ATC N01BB52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Aminacrine hydrochloride + Lignocaine hydrochloride
- Manufacturer
- Phoenix Labs
- Country
- Ireland (IE)
- ATC code
- N01BB52
- ATC class
- Lidocain, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1113/022/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocain, kombinationen in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Iglu, Iglu Rapid Relief
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08edaeec-79e4-49ad-b85d-be781cfa4dea GET /v1/drugs/08edaeec-79e4-49ad-b85d-be781cfa4dea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oromucosal gel",
"routes": [
"Oromucosal use"
],
"source": "hpra",
"atc_all": [
"D08AA",
"N01BB52"
],
"strength": null,
"pa_number": "PA1113/022/001",
"substances": [
"Aminacrine hydrochloride",
"Lignocaine hydrochloride"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "30/04/1984",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lidocain, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.